Riley Ennis

Riley Ennis has a varied work experience, beginning with their role as a Thiel Fellow at The Thiel Foundation in 2013. Riley then held a number of roles in 2014, including Co-Founder, CPO at Freenome, Co-Founder, Board Member and Advisor at Oncolinx, Investment Banking Summer Analyst at Morgan Stanley, and Visiting Scientist at Novartis. In 2015, they worked as a Bioinformatics at Foundation Medicine, and in 2014 they were a Winter Management Associate at Bridgewater Associates.

Riley Ennis attended Thomas Jefferson High School for Science and Technology from 2007 to 2011. Riley then went on to earn a Bachelor of Arts (B.A.) in Molecular Biology from Dartmouth College between 2011 and 2016. In 2013, they completed a Pre-MBA Global Leadership Program at Yale School of Management. Finally, they are currently pursuing a Master's in Biotechnology from The Johns Hopkins University, which they expect to complete in 2017.